Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Gynecol Oncol. 2016 Oct 7;143(3):484–489. doi: 10.1016/j.ygyno.2016.10.003

Table 1.

Eligible patient demographics and clinical characteristics (N = 420). Describes clinicopatholigic characteristics of this cohort of patients.

N
Age (years) 48.9 57.1 64.8
BMI (kg/m2) 21.5 24.3 28.5
Race/Ethnicity
 White 91% (384)
 Black 4.5% (9)
Performance status
 0 71% (300)
 1 24% (99)
Grade (differentiation)
 good 11.4% (48)
 moderate 37.9% (159)
 poor 49.5% (208)
Histology
 serous adenocarcinoma 69.8% (293)
 endometrioid adenocarcinoma 11.7% (49)
 mixed epithelial carcinoma 8.1% (34)
 clear-cell carcinoma 4.3% (18)
Gross residual disease
 no 36% (153)
 yes 64% (267)
Surgical interval days 28 63 83
No. complete IP cycles 2 6 6
Protocol number
 GOG 114 52% (220)
 GOG 172 48% (200)

a b c represent the lower quartile a, the median b, and the upper quartile c for continuous variables.

N is the number of non–missing values.

Numbers after percents are frequencies.